Financial PerformanceFinancial results show continued growth in an expanding market, meeting growth expectations both sequentially and in year-over-year comparisons.

Product InnovationZomedica has introduced several new assays for use with its TRUFORMA diagnostics platform, allowing veterinary practices to run tests without sending samples to an outside lab.

Sales GrowthThe TRUFORMA assays have been one of the sources of sales growth over the past year.

Bears Say

Price WeaknessAlthough Zomedica has made fundamental progress, the price weakness led to delisting and further price weakness.

Stock Price And DelistingThe closing price of Zomedica stock fell below $0.10 per share, forcing the delisting of ZOM shares.

Zomedica News

Zomedica Achieves Record Revenue Growth in Q2 2025

Zomedica ( ($ZOMDF) ) has provided an update. Zomedica reported a 14% increase in revenue for the second...

8d ago

Zomedica Shareholders Approve Directors, Reject Compensation

Zomedica ( ($ZOMDF) ) has provided an update. On June 10, 2025, Zomedica held its annual shareholder meeting...

2M ago

Zomedica Reports Q1 2025 Growth Amid Strategic Expansion

Zomedica Pharma ( ($ZOMDF) ) has released its Q1 earnings. Here is a breakdown of the information Zomedica...

3M ago

ZOMDF

Zomedica CFO Scott Jordan Resigns, Interim Replacement Named

The latest announcement is out from Zomedica ( ($ZOMDF) ). On April 25, 2025, Scott Jordan resigned as...

4M ago

Zscaler, Rocket Lab, American Tower, Intuit, and Zomedica: Insider Moves Unveiled!

Insiders have been trading these 5 stocks: (($ZS)), (($RKLB)), (($AMT)), (($INTU)) and (($ZOMDF)). Here is a breakdown of...

5M ago

AMT

Zomedica’s Earnings Call: Growth Amid Challenges

Zomedica Pharma (($ZOMDF)) has held its Q4 earnings call. Read on for the main highlights of the call....

5M ago

ZOMDF

Zomedica Achieves Record Revenue and Strategic Growth in 2024

Zomedica ( ($ZOMDF) ) has issued an announcement. Zomedica reported record revenue of $7.9 million for the fourth...

5M ago

Zomedica Reports Record Revenue and Strong Growth

Zomedica Pharma ( ($ZOMDF) ) has released its Q4 earnings. Here is a breakdown of the information Zomedica...

5M ago

ZOMDF

ZOMDF FAQ

What was Zomedica’s price range in the past 12 months?

Zomedica lowest stock price was $0.01 and its highest was $0.16 in the past 12 months.

What is Zomedica’s market cap?

Zomedica’s market cap is $39.69M.

When is Zomedica’s upcoming earnings report date?

Zomedica’s upcoming earnings report date is Nov 17, 2025 which is in 95 days.

How were Zomedica’s earnings last quarter?

Zomedica released its earnings results on Aug 06, 2025. The company reported -$0.01 earnings per share for the quarter, missing the consensus estimate of -$0.009 by -$0.001.

Is Zomedica overvalued?

According to Wall Street analysts Zomedica’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Zomedica pay dividends?

Zomedica does not currently pay dividends.

What is Zomedica’s EPS estimate?

Zomedica’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Zomedica have?

Zomedica has 979,949,650 shares outstanding.

What happened to Zomedica’s price movement after its last earnings report?

Zomedica reported an EPS of -$0.01 in its last earnings report, missing expectations of -$0.009. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Zomedica?

Currently, no hedge funds are holding shares in ZOMDF

Zomedica Stock Smart Score

Neutral

Fundamentals

Return on Equity

-50.95%

Trailing 12-Months

Asset Growth

-37.93%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Zomedica

Zomedica Pharmaceuticals Corp. is a veterinary health company focused on providing innovative diagnostic and therapeutic products for companion animals such as dogs and cats. Operating within the veterinary pharmaceuticals and diagnostics sector, Zomedica aims to improve the quality of pet care by developing products that enhance the capabilities of veterinarians to diagnose and treat their animal patients effectively. Their core offerings include diagnostic platforms and other veterinary medical devices.

Zomedica (ZOMDF) Earnings & Revenues

Historic Earnings Reports

ZOMDF Earnings Call

Q1 2025

0:00 / 0:00

Earnings Call Sentiment|Neutral

Zomedica's earnings call highlighted strong revenue growth, especially in the diagnostics segment, and successful international expansion. However, these positives were countered by significant challenges, including the delisting from the NYSE and an increased net loss. The company's strong liquidity position and product innovation are promising, but these are tempered by market and operational challenges.View all ZOMDF earnings summaries